DEARBORN PARTNERS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEARBORN PARTNERS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2015$588,000
-2.8%
13,095
-19.0%
0.05%
-8.9%
Q4 2014$605,000
+3.6%
16,165
-3.4%
0.06%
-1.8%
Q3 2014$584,000
+26.7%
16,735
+28.1%
0.06%
+26.7%
Q2 2014$461,000
+41.8%
13,065
+31.2%
0.04%
+28.6%
Q1 2014$325,000
-22.6%
9,9600.0%0.04%
-28.6%
Q4 2013$420,000
-0.2%
9,960
-5.7%
0.05%
-10.9%
Q3 2013$421,000
-3.7%
10,5600.0%0.06%
-11.3%
Q2 2013$437,00010,5600.06%
Other shareholders
HAEMONETICS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders